A drug
called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a clinical trial published in the Journal of Clinical Oncology.
Researchers at the University of Sheffield investigated a drug
called dasatinib, which works by blocking certain chemical signals that stimulate the growth of cancer cells.
Not exact matches
The researchers observed that two drugs each killed a large fraction of the cells that had begun transitioning:
dasatinib, a drug that targets the Src Family Kinase (SFK) and RK20449, a new drug in pre-clinical testing that specifically targets one of the SFK proteins
called Hck.